INTRODUCTION
The urea-cycle enzyme argininosuccinate lyase (ASL; EC 4.3.2.1) is under multi-hormonal control during development and represents a convenient model for study of regulation of gene expression in foetal mammalian hepatocytes. The enzyme protein and its corresponding mRNA first appear in foetal-rat liver about 6 days before birth [1] . Their levels rise slowly as term approaches and then rise rapidly during the first postnatal day [2] [3] [4] . They reach the adult level about 3 weeks after birth [4] . The mechanisms that are responsible for this perinatal development have not yet been completely clarified. Glucocorticoids and glucagon have been implicated in the developmental regulation of this enzyme activity [3] [4] [5] [6] [7] as well as its maintenance in the adult rat liver [8] [9] [10] [11] . Glucocorticoids are thought to induce ASL by activating transcription [12, 1] , and we asked whether glucagon acts through a similar mechanism. In adult rat liver, glucagon was shown to produce an increase in enzyme activity [9, 10] and in the amount of ASL mRNA, in vivo [12] as well as in vitro [13] . Our previous results obtained during the foetal period showed that glucagon or dibutyryl cyclic AMP (Bt2cAMP) could cause premature induction of the enzyme activity when injected into foetal rats [7, 14] or when added to cultured foetal hepatocytes [15, 16] . This system allows maintenance of measurable levels of ASL mRNA in control medium for a few days [1] and thus offers a suitable model to study the developmental regulation of this gene expression.
To establish whether the increase in ASL activity after glucagon treatment is regulated at a transcriptional or translational level, an immunochemical test (e.l.i.s.a.) was used to quantify the amount of ASL [4] , and we measured hybridizable ASL mRNA using a cDNA probe [17] [20] with some modifications [15] . The Enzymic and immunochemical tests Foetal hepatocytes were homogenized in 0.1 % cetyltrimethylammonium bromide. Assay of ASL, based on the colorimetric determination of urea, was performed by the procedure of Tomlinson and Westall [21] . The enzyme activity was expressed in ,umol of urea formed/h (units) per mg of protein. Quantification ofASL in foetal hepatocytes was performed by a 'sandwich non-competitive e.l.i.s.a.' developed in this laboratory [4] . Immobilized purified IgG was incubated with purified ASL as standard or with hepatocyte extracts for tests. After washing, the immobilized antibody-antigen complex was incubated with an excess of peroxidase-labelled antibody, which bound to the remaining antigenic sites. After incubation with peroxidase substrate, the reaction product was measured at 405 nm. The amount of ASL was given as 4ag of protein. The protein content of homogenates was determined by the method of Lowry et al. [22] , with BSA as standard. Significance was determined by Student's t test.
Extraction and analysis of cellular RNA Isolation of total cellular RNA was performed with hepatocytes from four pooled flasks. The monolayers were rapidly washed with phosphate-buffered saline, pH 7.5, and scraped with a rubber spatula. Hepatocytes were collected by centrifugation for 5 min at 700 g, frozen in liquid nitrogen and stored at -70°C before homogenization. Total cellular RNA was extracted by the guanidinium thiocyanate procedure of Cathala et al. [23] . The RNA fractions were precipitated with ethanol and stored at -70 'C. The purity of total RNA was estimated by spectrophotometry (A260/A280) and its integrity was verified by electrophoresis in agarose gels with detection by ethidium bromide u.v. fluorescence. RNA concentrations were determined from the A260. For Northern blotting analysis, 25 4ag of total RNA was denatured in formaldehyde and electrophoresed on a 1.2 %-formaldehyde/agarose gel [24] , then blotted overnight on to nylon sheets. Procedures for pre-hybridization, hybridization and post-hybridization washings were performed in accordance with the instructions ofthe membrane manufacturer. Radioactive labelling of the cDNA probes was done with [a-32PJdCTP, with random oligonucleotides as primers. Hybridizations were performed overnight at 42°C and the nylon sheets were finally exposed to Kodak XR-5 film at -70°C for periods in the range 6-48 h, by using intensifying screens. Several different exposures were obtained for each blot to optimize the subsequent analyses of the autoradiograms. The intensity of the bands observed on the autoradiograms was quantified by scanning the film with a Shimadzu (CS-930) densitometer.
RESULTS AND DISCUSSION Effects of glucagon and cyclic nucleotide analogues on ASL activity and amount Hepatocytes from 18.5-day foetuses were cultured for 24 h in control medium; then 0.1 ,uM glucagon, 0.5 mM Bt2cAMP or 50 ,uM CPT-cAMP was added for an additional 24 h. The ASL activity and amount of immunoreactive protein were first determined and then compared with amounts of specific mRNA. ASL activity was previously shown to attain maximal levels about 20 h after glucagon addition [16] , where it was increased about 2-fold over the control values. Table 1 shows that this induced activity was linked to a similar increase in the amount of immunoreactive protein, as measured by the e.l.i.s.a. method. When foetal hepatocytes were exposed to glucagon, Bt2cAMP or CPT-cAMP and dexamethasone together, the ASL activity and amount increased additively, suggesting that the two agents acted via independent pathways.
The good correlation between both parameters (activity and amount) leads to the conclusion that the rise in ASL activity measured after hormonal treatments was due to enzyme synthesis.
Effects of glucagon and Bt2cAMP on ASL mRNA
To understand better the process underlying this cAMP-evoked induction of ASL, we examined the accumulation of specific mRNA in such treated hepatocytes. The effects of individual compounds on ASL mRNA levels were first studied at 48 h of culture by Northern-blot analysis, and a representative experiment is shown in Figure 1 . Although dexamethasone produced a marked increase in ASL mRNA, glucagon (Figure Table 1 Effects of glucagon, Bt2cAMP, CPT-cAMP and dexamethasone on ASL activity and amount in cultured foetal hepatocytes Hepatocytes from 18.5-day foetuses were cultured for 24 h in control medium, and then for another 24 h with the different indicated compounds. Figure 2( The fact that the increase in enzyme amount and activity lagged behind the increase in mRNA levels might be explained by the different half-life of the protein ASL and its corresponding mRNA. The half-life ofthe urea-cycle enzymes has been proposed to be in the range of a few days [25] , and our results on mRNA stability suggest that the half-life ofASL mRNA can be evaluated as hours (S. Renouf, A. Fairand and A. Husson, unpublished work). Another possibility to explain the different time course of response is that a translational mechanism might control the ASL amount and prevent short-term variations of mRNA. This phenomenon was already observed at birth, when ASL mRNA accumulated sharply in a few hours, whereas the ASL protein accumulated only after a lag time [4] . Such a rapid rise and fall in specific mRNA levels were also observed for tyrosine aminotransferase in cAMP-treated rat foetuses [26] .
To understand better the mechanism of the transitory nature of the cAMP-evoked induction of ASL mRNA, we examined the effects of addition and re-addition of Bt2cAMP to cultured foetal hepatocytes. Fresh Bt2cAMP re-added at 6 h, when the induction had reached a peak, failed to evoke a new induction of ASL mRNA (Figure 3) , whose level decreased similarly as in the preceding experiment (Figure 2a) . Similar results were obtained with 50 ,uM Bt2cAMP (results not shown). This suggests that the cyclic nucleotide was still in a sufficient amount in the medium 6 h after its addition and might reveal a desensitization of the cells towards stimulation by Bt2cAMP [271.
This time course of induction by Bt2cAMP was different from that obtained from experiments with dexamethasone, where a longer lag period and slower induction kinetics were observed [1] . In particular, the mRNA amount in foetal hepatocytes incubated with dexamethasone remained at a high level for at least 48 h. It was previously shown in Table 1 that the effects of cAMP and glucocorticoids on ASL activity were additive, suggesting that they affect different steps in the synthesis of ASL. We have therefore analysed the combined effects of dexamethasone and Bt2cAMP at the level of ASL mRNA. At 6 h of incubation, the combined effects of maximal doses of both compounds were approximately additive (Figure 4 ), since the cyclic nucleotide analogue alone caused about a 2-fold stimulation of ASL mRNA accumulation and a 4-fold one in cells simultaneously incubated with dexamethasone, as evidenced by scanning the autoradiogram of Figure 4 . These data indicate that glucocorticoids and cAMP are both necessary to promote differentiation of foetal hepatocytes, and give further support to the idea that the two inducers act by independent mechanisms to elevate the level of this mRNA.
Effects of actinomycin D and puromycin on ASL mRNA levels
The regulation of the synthesis of ASL by cAMP could occur at the level of transcription, or might be the consequence of altered stability of the specific mRNAs. To gain better understanding between these alternatives, we used a RNA-synthesis inhibitor, actinomycin D, and CPT-cAMP ( Figure 5a ). As cAMP promotes foetal hepatocyte differentiation in vitro [31] at the level of mRNA synthesis. Glucagon has been shown to regulate gene expression by different mechanisms, and some studies have shown the existence of cAMP-responsive elements on specific genes, such as those for PEPCK [32] , tyrosine aminotransferase [33] , tyrosine hydroxylase [34] and arginase [35] . The ASL gene has been analysed [36] and, although a part of the 5' flanking region has been sequenced [37] , functional cAMPresponsive elements have not yet been described, and we do not know whether any sequence elements are actually involved in the response of this gene. Whatever the required mechanism in the cAMP regulation of the ASL gene, our study shows that this mechanism is already functional during foetal life.
